ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic
December 23, 2020The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Swiss biotech Polyphor’s first-in-human phase I study of its novel inhaled antibiotic murepavadin. -
Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including overall survival
October 25, 2018Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including overall survival -
Polyphor launches the development of an inhaled antibiotic murepavadin
October 13, 2017Polyphor Ltd has announced €5m funding, in order to support and accelerate the development of an inhaled dosage form of murepavadin…
Pharma Sources Insight January 2025
